Literature DB >> 10754291

Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.

A X Mo1, S F van Lelyveld, A Craiu, K L Rock.   

Abstract

The proteasome has been shown to make the proper C-terminal cleavage for the generation of several immunodominant class I-presented peptides whereas aminopeptidases generate their proper N termini. In this study, we show that these two distinct proteolytic processes are also involved in generating a subdominant OVA peptide KVVRFDKL (K-L). Moreover, proteasome inhibitors did not enhance the presentation of any K-L construct, suggesting that destruction of this peptide by proteasomes, if any, does not limit its presentation. We have further examined in intact cells the influence of residues flanking this epitope on these proteolytic processes. When the N-terminal flanking residues of K-L are fused to an immunodominant OVA peptide SIINFEKL (S-L), the presentation of S-L is reduced as compared with a construct with its natural flanking sequence and was not inhibited (or enhanced) by proteasome inhibitors. Similarly, a reduction in presentation was observed when the C-terminal flanking residues of the subdominant epitope were attached to S-L. A detailed analysis revealed that the Pro at the P1' position of K-L was responsible for this reduction, and presentation of these C-terminally extended constructs was sensitive to proteasome inhibitor. The study suggests that both the N- and C-terminal flanks of the subdominant peptide are suboptimal for Ag presentation. Moreover, three of four C-terminal residues that flank other subdominant or cryptic epitopes in OVA reduced the presentation of S-L. Therefore, the residues that flank the C termini of several subdominant and cryptic epitopes are often suboptimal for cleavage and may contribute to the phenomenon of immunodominance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754291     DOI: 10.4049/jimmunol.164.8.4003

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors:  Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal:  Immunogenetics       Date:  2003-08-30       Impact factor: 2.846

3.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells.

Authors:  Eleanor J Cheadle; Dearbhaile O'Donnell; Peter J Selby; Andrew M Jackson
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  High-frequency vaccine-induced CD8⁺ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection.

Authors:  Thomas Lindenstrøm; Claus Aagaard; Dennis Christensen; Else M Agger; Peter Andersen
Journal:  Eur J Immunol       Date:  2014-03-27       Impact factor: 5.532

6.  Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes.

Authors:  Paolo Cascio; Matthew Call; Benjamin M Petre; Thomas Walz; Alfred L Goldberg
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

7.  Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies.

Authors:  Jinyan Liu; Bonnie A Ewald; Diana M Lynch; Anjali Nanda; Shawn M Sumida; Dan H Barouch
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

8.  The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation.

Authors:  Xueying Ma; Amparo Serna; Ren-Huan Xu; Luis J Sigal
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.

Authors:  Ayub Ali; Rachel Lubong; Hwee Ng; David G Brooks; Jerome A Zack; Otto O Yang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.